13F filer · CIK 1422848 ↗
Capital Research Global Investors
You are looking at Q4 2022. See the latest, Q2 2026 →
Reported value
$330.88B
+8.7% on the quarter before
Positions
436
38 new · 31 sold out
Top 10
27.1%
of the value
Est. gain
+$27.56B
on stocks held all quarter
Est. return
+9.9%
on those stocks since Q3 2022
Positions as of Dec 31, 2022, from Capital Research Global Investors's 13F filing with the SEC. A 13F lists a manager's US-listed stocks and options at a quarter end and is filed up to 45 days later, so the fund may hold something else today. It leaves out short positions, cash and holdings outside the US.
Portfolio at a glance
- New
- Added
- Cut
- Same
- Options
The 24 largest positions, 43% of the reported value, each sized by its share, colored by what the fund did with it since Q3 2022. Striped tiles are options.
Largest buys
Since Q3 2022, by estimated size: the change in shares at the quarter-end price, since a 13F gives no trade prices. Percentages are the position's share of the portfolio, before and after.
- Boeing Co~$1.54BNew · 0.0% → 0.5%+8,097,785 shares
- D R Horton Inc~$1.12BAdded · 0.4% → 0.8%+12,574,237 shares
- Nvidia~$967.0MNew · 0.0% → 0.3%+6,617,082 shares
- Netflix~$943.2MAdded · 1.2% → 1.7%+3,198,772 shares
- General Electric Co~$923.7MAdded · 1.9% → 2.6%+11,024,253 shares
- Micron~$863.6MAdded · 0.8% → 1.0%+17,279,374 shares
- Altria Group Inc~$672.6MAdded · 0.3% → 0.5%+14,714,666 shares
- Canadian Nat Res Ltd~$665.9MAdded · 1.3% → 1.6%+11,991,380 shares
- BlackRock~$638.6MAdded · 0.2% → 0.4%+901,154 shares
- American Intl Group Inc~$609.5MAdded · 0.5% → 0.8%+9,638,037 shares
Largest sells
Since Q3 2022, by estimated size: the change in shares at the quarter-end price, since a 13F gives no trade prices. Percentages are the position's share of the portfolio, before and after.
- Alphabet~$1.58BCut · 1.6% → 0.9%−17,890,568 shares
- Apple~$1.54BCut · 1.7% → 1.0%−11,872,179 shares
- Amazon~$1.47BCut · 3.9% → 2.2%−17,493,511 shares
- Alphabet~$1.43BCut · 1.5% → 0.9%−16,145,744 shares
- Microsoft~$1.22BCut · 6.4% → 5.7%−5,078,184 shares
- Thermo Fisher Scientific Inc~$880.3MCut · 1.5% → 1.2%−1,598,526 shares
- Philip Morris Intl Inc~$821.8MCut · 1.7% → 1.7%−8,119,904 shares
- Unitedhealth Group Inc~$737.4MCut · 3.1% → 2.8%−1,390,939 shares
- Atlassian Corp Plc~$720.4MSold out · 0.2% → 0.0%−3,420,789 shares
- Burlington Stores Inc~$715.5MCut · 0.2% → 0.1%−3,528,741 shares
Holdings
As of Dec 31, 2022. Changes are in shares against Sep 30, 2022, so a price move alone never reads as a buy or a sale.
| Holding | Value | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| MicrosoftCOM · shares −6.1% · price +3.0% | 5.7% | $18.72B | +$540.1M | ||||||||
| BroadcomCOM · shares +2.8% · price +25.9% | 3.7% | $12.19B | +$2.44B | ||||||||
| Unitedhealth Group IncCOM · shares −7.4% · price +5.0% | 2.8% | $9.18B | +$435.0M | ||||||||
| General Electric CoCOM NEW · shares +12% · price +35.3% | 2.6% | $8.55B | +$1.99B | ||||||||
| Abbott LabsCOM · shares −2.6% · price +13.5% | 2.5% | $8.43B | +$1.00B | ||||||||
| Raytheon Technologies CorpCOM · shares +3.8% · price +23.3% | 2.5% | $8.15B | +$1.48B | ||||||||
| AmazonCOM · shares −17% · price −25.7% | 2.2% | $7.35B | −$2.54B | ||||||||
| Abbvie IncCOM · shares +1.4% · price +20.4% | 1.8% | $5.93B | +$991.7M | ||||||||
| Philip Morris Intl IncCOM · shares −13% · price +21.9% | 1.7% | $5.56B | +$1.00B | ||||||||
| NetflixCOM · shares +21% · price +25.2% | 1.7% | $5.47B | +$911.9M | ||||||||
| Canadian Nat Res LtdCOM · shares +14% · price +19.3% | 1.6% | $5.38B | +$761.8M | ||||||||
| MastercardCL A · shares +8.0% · price +22.3% | 1.5% | $4.80B | +$810.4M | ||||||||
| Gilead Sciences IncCOM · shares +1.4% · price +39.2% | 1.4% | $4.69B | +$1.30B | ||||||||
| Comcast Corp NewCL A · shares +5.0% · price +19.2% | 1.3% | $4.24B | +$650.7M | ||||||||
| Thermo Fisher Scientific IncCOM · shares −18% · price +8.6% | 1.2% | $3.94B | +$311.4M | ||||||||
| Linde PlcSHS · shares +0.04% · price +21.0% | 1.2% | $3.87B | +$670.6M | ||||||||
| MetaCL A · shares +5.6% · price −11.3% | 1.2% | $3.83B | −$462.5M | ||||||||
| AppleCOM · shares −31% · price −6.0% | 1.0% | $3.45B | −$219.9M | ||||||||
| Stryker CorporationCOM · shares +11% · price +20.7% | 1.0% | $3.44B | +$529.9M | ||||||||
| Baker HughesCL A · shares −6.2% · price +40.9% | 1.0% | $3.44B | +$997.4M | ||||||||
| Pg&E CorpCOM · shares −0.3% · price +30.1% | 0.98% | $3.25B | +$752.1M | ||||||||
| Eog Res IncCOM · shares +6.1% · price +15.9% | 0.98% | $3.24B | +$419.2M | ||||||||
| MicronCOM · shares +36% · price −0.2% | 0.98% | $3.24B | −$5.7M | ||||||||
| Carrier GlobalCOM · shares −5.1% · price +16.0% | 0.97% | $3.22B | +$444.8M | ||||||||
| Amgen IncCOM · shares −5.5% · price +16.5% | 0.95% | $3.13B | +$443.8M | ||||||||
| Total · 436 positions | 100% | $330.88B | +$27.56B |
Price is a stock's reported value over its shares at the quarter end. The estimated gain is the shares held at both quarter ends times the change in that price: shares bought or sold during the quarter add nothing, options are left out, and a stock split is read into the earlier share count and price.
What made money
From Q3 2022 to Q4 2022: 395 stocks held throughout, up $27.56B (+9.9%).
- Broadcom+$2.44B+26%
- General Electric Co+$1.99B+35%
- Raytheon Technologies Corp+$1.48B+23%
- Gilead Sciences Inc+$1.30B+39%
- Abbott Labs+$1.00B+13%
- Meta−$462.5M−11%
- Wolfspeed−$467.7M−33%
- Rivian Automotive Inc−$515.4M−44%
- Tesla−$912.2M−54%
- Amazon−$2.54B−26%
Estimated as in the holdings table: shares held at both quarter ends times the change in price; options left out, 1 split read into the share counts.
Reported value by quarter
The total value of each quarter's 13F at that quarter end. It moves with prices as well as with buying and selling. Pick a quarter to see what the fund held then.
Every quarter's filing
| Quarter | Reported value | Filing | |
|---|---|---|---|
| Q2 2026 | Aug 12, 2026 | $716.87B+11% | SEC ↗ |
| Q1 2026 | May 13, 2026 | $644.56B+19% | SEC ↗ |
| Q4 2025 | Feb 11, 2026 | $541.73B+2% | SEC ↗ |
| Q3 2025 | Nov 13, 2025 | $532.97B+7% | SEC ↗ |
| Q2 2025 | Aug 13, 2025 | $499.46B+9% | SEC ↗ |
| Q1 2025 | May 12, 2025 | $459.90B−5% | SEC ↗ |
| Q4 2024 | Feb 13, 2025 | $486.38B+1% | SEC ↗ |
| Q3 2024 | Nov 13, 2024 | $481.14B+6% | SEC ↗ |
| Q2 2024 | Aug 13, 2024 | $455.74B+3% | SEC ↗ |
| Q1 2024 | May 14, 2024 | $441.98B+9% | SEC ↗ |
| Q4 2023 | Feb 13, 2024 | $406.47B+12% | SEC ↗ |
| Q3 2023 | Nov 13, 2023 | $363.16B−3% | SEC ↗ |
| Q2 2023 | Aug 11, 2023 | $373.18B+7% | SEC ↗ |
| Q1 2023 | May 15, 2023 | $350.40B+6% | SEC ↗ |
| Q4 2022 | Feb 14, 2023 | $330.88B+9% | SEC ↗ |
| Q3 2022 | Nov 14, 2022 | $304.37B−5% | SEC ↗ |
| Q2 2022 | Aug 15, 2022 | $321.05B−21% | SEC ↗ |
| Q1 2022 | May 19, 2022 (amended) | $405.10B−11% | SEC ↗ |
| Q4 2021 | Feb 14, 2022 | $452.67B+6% | SEC ↗ |
| Q3 2021 | Nov 15, 2021 | $428.65B−0% | SEC ↗ |
| Q2 2021 | Aug 16, 2021 | $429.52B+5% | SEC ↗ |
| Q1 2021 | May 14, 2021 | $408.71B+6% | SEC ↗ |
| Q4 2020 | Feb 12, 2021 | $385.30B+16% | SEC ↗ |
| Q3 2020 | Nov 13, 2020 | $333.11B+5% | SEC ↗ |
| Q2 2020 | Aug 14, 2020 | $316.13B+24% | SEC ↗ |
| Q1 2020 | May 15, 2020 | $254.90B−24% | SEC ↗ |
| Q4 2019 | Feb 18, 2020 | $333.48B+9% | SEC ↗ |
| Q3 2019 | Nov 14, 2019 | $304.85B−3% | SEC ↗ |
| Q2 2019 | Aug 14, 2019 | $314.99B−0% | SEC ↗ |
| Q1 2019 | May 15, 2019 | $315.45B+10% | SEC ↗ |
| Q4 2018 | Feb 14, 2019 | $287.02B−17% | SEC ↗ |
| Q3 2018 | Nov 14, 2018 | $344.02B−6% | SEC ↗ |
| Q2 2018 | Aug 14, 2018 | $366.12B+4% | SEC ↗ |
| Q1 2018 | May 15, 2018 | $351.43B+3% | SEC ↗ |
| Q4 2017 | Feb 14, 2018 | $340.76B+3% | SEC ↗ |
| Q3 2017 | Nov 14, 2017 | $331.24B+4% | SEC ↗ |
| Q2 2017 | Aug 14, 2017 | $319.49B+1% | SEC ↗ |
| Q1 2017 | May 15, 2017 | $317.04B+3% | SEC ↗ |
| Q4 2016 | Feb 15, 2017 | $308.47B+2% | SEC ↗ |
| Q3 2016 | Nov 14, 2016 | $302.53B+3% | SEC ↗ |
| Q2 2016 | Aug 15, 2016 | $292.47B+1% | SEC ↗ |
| Q1 2016 | May 16, 2016 | $290.06B | SEC ↗ |